Abstract
IN-VIVO EVALUATION OF PREGABLIN AND 4-ISOBUTYLPYRROLIDIN-2-ONE USING ANIMAL MODELS
Dr. Syed Ahmed Hussain*, Juveria, Atika Tahreem and Ayesha Tanveer
ABSTRACT
Antiepileptic drugs on the market now can treat 50 to 80 percent of epilepsy patients. 10% to 20% of individuals taking these drugs report no improvement in seizure control. The extraction of the chemical chloroform has been significantly delayed. COMPOUND was used to lessen the quantity of LPO. The antioxidant properties of COMPOUND were demonstrated in MES-initiated shaking models by a decrease in lipid peroxidation and an increase in glutathione levels. If the free radical rummaging movement stops, repeat seizures may become more common. The treated bunches had different neuronal mobility than the control, meo-, and high-dose COMPOUND bunches. As compared to the control, the compound significantly boosted GABA levels, as well as DA, NA, and 5-HT levels.
[Full Text Article] [Download Certificate]WJPLS CITATION
All | Since 2019 | |
Citation | 422 | 322 |
h-index | 9 | 7 |
i10-index | 4 | 2 |
INDEXING
NEWS & UPDATION
BEST ARTICLE AWARDS
World Journal of Pharmaceutical and life sciences is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.
Best Article of current issue
Download Article : Click here